Clinical management of thalassemia in adults;Klinisches management einer thalassämie beim erwachsenen patienten

Therapeutische Umschau

Volumn 67, Issue 5, 2010, Pages 237-243

  Tichelli, André ^a   Rovó, Alicia ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE MESYLATE; HEMOGLOBIN A; HEMOGLOBIN A2; HEMOGLOBIN F;

BONE DISEASE; EXTRAMEDULLARY HEMATOPOIESIS; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HEMATOLOGY; HUMAN; HYPERCOAGULABILITY; INFERTILITY; IRON CHELATION; IRON OVERLOAD; LIFE EXPECTANCY; PATIENT COUNSELING; PREGNANCY; REVIEW; RISK FACTOR; THALASSEMIA MAJOR; THALASSEMIA MINOR;

ADULT; CRITICAL CARE; FEMALE; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THALASSEMIA;

EID: 77953166822     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930/a000043     Document Type: Review

References (10)

1. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ: Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008; 10: 42.
2. Galanello R: A thalassemic child becomes adult. Rev Clin Exp Hematol 2003; 7: 4-21.
3. Borgna-Pignatti C, Rugolotto S, De SP, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A: Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89: 1187-1193 (Pubitemid 39390442)
4. Bhatia M, Walters MC: Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant 2008; 41: 109-117 (Pubitemid 351188907)
5. Cazzola M, Borgna-Pignatti C, Locatelli F, Ponchio L, Beguin Y, De SP: A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion 1997; 37: 135-140 (Pubitemid 27091897)
6. Hoffbrand AV, Cohen A, Hershko C: Role of deferiprone in chelation therapy for transfusional iron overload. Blood 2003; 102: 17-24. (Pubitemid 36759630)
7. Wonke B: Bone disease in beta-thalassaemia major. Br J Haematol 1998; 103: 897-901.
8. Voskaridou E, Anagnostopoulos A, Konstantopoulos K, Stoupa E, Spyropoulou E, Kiamouris C, Terpos E: Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial. Haematologica 2006; 91: 1193-1202 (Pubitemid 44408429)
9. Eldor A, Rachmilewitz EA: The hypercoagulable state in thalassemia. Blood 2002; 99: 36-43.
10. Borgna PC, Carnelli V, Caruso V, Dore F, De MD, Di PA, Di GF, Romeo MA, Longhi R, Mangiagli A, Melevendi C, Pizzarelli G, Musumeci S: Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 1998; 99: 76-79 (Pubitemid 28119099)